Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
02/2007
02/15/2007WO2007017509A1 Compounds for the treatment of alzheimer's disease
02/15/2007WO2007017414A1 Substituted malononitrile compounds for combating animal pests
02/15/2007WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives
02/15/2007WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives
02/15/2007WO2006073963A3 Process for removal of sulfur from components for blending of transportation fuels
02/15/2007US20070037976 Method for producing an optically active nitro compound
02/15/2007US20070037890 Cannabinoids
02/15/2007US20070037870 Novel substance having alpha-glucosidase inhibiting activity and food containing the same
02/15/2007US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
02/15/2007US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide
02/15/2007US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists.
02/15/2007US20070037813 Serine Protease Inhibitors
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system
02/15/2007US20070037012 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
02/15/2007CA2618888A1 Acyltryptophanols for fertility control
02/15/2007CA2618474A1 Compounds for treating alzheimer's disease
02/15/2007CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007CA2618019A1 Compounds for the treatment of alzheimer's disease
02/15/2007CA2617473A1 Acylguanidine derivative or salt thereof
02/14/2007EP1752440A1 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound
02/14/2007EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
02/14/2007EP1581513B1 Multifunctional cationic photoinitiators, their preparation and use
02/14/2007EP1368336B9 Thiophene substituted amine derivatives as glyt-1 inhibitors
02/14/2007EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
02/14/2007CN1914509A Time-temperature indicator based on valence isomerizations
02/14/2007CN1914190A Method for producing enantiomer-pure aminoalcohols
02/14/2007CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/14/2007CN1300137C Method for preparing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl) propylamine
02/14/2007CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/13/2007CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
02/13/2007CA2239618C Improved metal-ligand complex catalyzed processes
02/13/2007CA2133899C Asymmetric synthesis of (s) - (+) -n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
02/08/2007WO2007015866A2 Inhibitors of p38 kinase and methods of treating inflammatory disorders
02/08/2007WO2007015744A1 Disubstituted thienyl compounds and their use as pharmaceuticals
02/08/2007WO2006117762A3 Antimicrobial agents
02/08/2007US20070032640 Cytokine receptor
02/07/2007EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases
02/07/2007EP1749165A2 Threaded connection for oil field applications
02/07/2007EP1748997A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
02/07/2007EP1748996A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
02/07/2007EP1748979A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
02/07/2007EP1748783A2 Treatment or prevention of respiratory viral infections with immunomodulator compounds
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1907970A Method for synthesizing heteroaryl thiosemicarbazone antineoplastic
02/07/2007CN1298709C Thiophene-and thiazolesulfonamides as antineoplastic agents
02/06/2007US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts
02/06/2007US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid
02/06/2007US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones
02/06/2007US7173060 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis
02/06/2007US7173052 Resorcinol for lightening skin removing color
02/06/2007US7173043 Heteroaromate OSC inhibitors
02/01/2007WO2007014273A2 Sulfonamides as selective estrogen receptor modulators
02/01/2007WO2007013694A1 Phenoxyalkanoic acid compound
02/01/2007WO2006132811A3 Ampa receptor potentiators
02/01/2007US20070028265 System and method for displaying editorial content through television navigation controls and electronic program guides
02/01/2007US20070027333 Stereoselective synthesis of vitamin d analogues
02/01/2007US20070027158 High affinity small molecule C5a receptor modulators
02/01/2007US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
02/01/2007US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators
02/01/2007US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
01/2007
01/31/2007EP1748046A2 Inhibitors of histone deacetylase
01/31/2007EP1748045A1 Light-emitting device material and light-emitting device
01/31/2007EP1747214A2 Dihydrobenzothiophenes
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747191A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
01/31/2007EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
01/31/2007EP1587801B1 A process for preparing duloxetine and intermediates for use therein
01/31/2007CN1903859A Method of preparing chloropy gra hydrogen sulphate type I
01/31/2007CN1903851A Preparation method of 2 substituted calcium malonate and use of calcium salt
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169954 Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol
01/30/2007US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
01/30/2007US7169938 Synthesis including (S)-3-Hydroxy-3-(2-thiophen-yl)-N-methylpropionamide, and (R)-3- hydroxy-3-(2-thiophen-yl)-N-methylpropionamide; intermediates to drugs such as fluoxetine
01/30/2007US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions.
01/30/2007US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK
01/30/2007US7169807 For therapy of asthma, dysmenorrhea, osteoporosis, bone disorders, constipation, renal disorders, sexual dysfunction, baldness, acute hepatitis, bronchitis, burn, chronic obstructive respiratory diseases, Crohn's disease, digestive ulcer, hemophagous syndrome, hepatopathy, hypercytokinemia at dialysis
01/30/2007US7169796 Polyarylcarboxamides useful as lipid lowering agents
01/30/2007CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy
01/30/2007CA2286723C Tricyclic compounds
01/30/2007CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
01/30/2007CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands
01/25/2007WO2007011945A1 Improved process for substituted polythiophene polymers
01/25/2007WO2007010954A1 Thiophene compounds and thrombopoietin receptor activators
01/25/2007WO2006074330A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
01/25/2007US20070021606 Therapeutic compounds
01/25/2007US20070021509 Phosphate transport inhibitors
01/25/2007US20070021495 Sulfonamides as selective estrogen receptor
01/25/2007US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
01/25/2007US20070021492 Sulfamatet benzothiophene derivatives as steroid sulfatase inhibitors